The Global Health Body Issues Warning Over Severe Scarcity of Obesity Injections
Less than one in 10 people eligible to benefit from weight-loss injections like Wegovy have access to them, warns the global health agency as it publishes its initial advice on the medications.
Considering in excess of 1,000,000,000 individuals worldwide now classified as obese, it is calling for more widespread and fairer availability to GLP-1 medication.
Per projections, in excess of 2,000,000,000 will be living with obesity by 2030 unless action is taken.
"Our latest guidance affirms that excess weight is a lifelong illness that can be managed with thorough and ongoing support," remarked its chief Tedros Adhanom Ghebreyesus.
High costs, constrained manufacturing, and logistical bottlenecks are significant barriers to broad availability to the injections that can assist patients in reducing significant weight, says the organization.
Skinny Jab Shortage
Even in the present most optimistic scenario, the production of such drugs might only reach approximately 100 million people – under 10% of those who need them, according to the health organization.
The guideline urges governments and firms to widen availability, via measures such as licensing agreements.
A patent on semaglutide – the core component of a leading brand – is set to lapse in a number of nations in 2026.
The Way Weight-Loss Injections Function
GLP-1 drugs imitate a natural hormone to delay gastric emptying, reduce hunger and enhance the sense of being full so users reduce food intake.
Individuals usually see weight reduction in the initial weeks of commencing the weekly injections.
Studies points to people may regain a significant portion a year later of halting the treatment, when their normal appetite resume.
To be overweight or obese increases your chance for contracting diseases, such as type 2 diabetes, cardiovascular issues, stroke, and some malignancies.
Obesity impacts people in countries worldwide and was linked to 3.7 million deaths worldwide in 2024, as per the health agency.
